NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Myosin Therapeutics Inc.

Myosin Therapeutics Inc.

Private
Jupiter, FloridaHealthcare & Life Scienceshttps://myosintherapeutics.com/

Last Round

Grant

Mar 19, 2026

Est. Valuation

$28M

Total Funding Raised

$15.5M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Myosin Therapeutics Inc. is a biotechnology company that develops novel pharmacotherapies targeting members of the myosin family of molecular motors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

biotechnologyoncologyglioblastomadrug discoveryclinical trialsbrain cancertargeted therapybiotech startupneuro-oncologysmall-molecule therapeuticsFDA fast trackbiopharmaclinical-stage biotechdrug developmenttherapeutic pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Myosin Therapeutics Inc. Comps

Public and private peers based on sector, stage, and business model.

Myosin Therapeutics Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Myosin Therapeutics Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 19, 2026
GrantAug 19, 2025
GrantApr 28, 2025
SeedFeb 26, 2025
SeedMar 14, 2023

Myosin Therapeutics Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 24, 2026

    $2M raised in grant funding.

  • Jan 29, 2026

    Invited to present at Biocom California's Global Partnering & Investor Conference.

Myosin Therapeutics Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Myosin Therapeutics Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Myosin Therapeutics Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersJupiter, Florida
Employee Range9
Year Founded2020
Last FundingMar 19, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.